From Casetext: Smarter Legal Research

Bocci v. Key Pharmaceuticals, Inc.

Oregon Court of Appeals
Nov 13, 2003
190 Or. App. 407 (Or. Ct. App. 2003)

Opinion

A9210-07050; A86556.

On respondent's petition for reconsideration filed September 24, 2003, and appellants' response to petition for reconsideration filed October 8, 2003. Opinion filed September 10, 2003. 189 Or. App. 349, 76 P.3d 669.

Filed: November 13, 2003.

On remand from the United States Supreme Court, Key Pharmaceuticals, Inc., et al. v. Frederick D. Edwards, 538 U.S. ___, 123 S.Ct. 1781, 155 L.Ed.2d 662 (2003).

Appeal from Circuit Court, Multnomah County. William C. Snouffer, Judge.

Daniel M. Holland, Ronald B. Terzerbach, Loomis Holland, Mary H. Spillane, Margaret A. Sundberg, and Williams, Kastner Gibbs PLLC for petition.

William F. Gary, Sharon A. Rudnick, James E. Mountain, Jr., and Harrang Long Gary Rudnick P.C. contra.

Before LANDAU, Presiding Judge, and ARMSTRONG and BREWER, Judges.


LANDAU, P.J.

Petition for reconsideration allowed; opinion modified and adhered to as modified.


Cross-claim plaintiff Frederick D. Edwards, M.D., petitions for reconsideration of our opinion in Bocci v. Key Pharmaceuticals, Inc., 189 Or. App. 349, 76 P.3d 669 (2003) ( Bocci III), making numerous arguments. We allow reconsideration to correct a misstatement of fact in the opinion, but adhere to our previous opinion in all other respects.

In our previous opinion, we quoted from Bocci II:

"`The jury awarded Bocci more than $5 million in compensatory damages and $35 million in punitive damages. The jury awarded Edwards $500,000 in compensatory damages and $22[.5] million in punitive damages.'"

Bocci III, 189 Or. App. at 352 (quoting Bocci v. Key Pharmaceuticals, Inc., 178 Or. App. 42, 46, 35 P.3d 1106 (2001) ( Bocci II)). However, later in the Bocci III opinion, we misstated that the "ratio of combined punitive damages ($55.5 million) to combined compensatory damages ($5.5 million) is in excess of 10 to 1." Bocci III, 189 Or. App. at 360. Edwards correctly points out that the combined punitive damages were actually $57.5 million and further notes that the combined compensatory award was $6,121,648, concluding that the ratio was not in excess of 10 to 1, but rather was 9.4 to 1. We therefore correct the above-quoted statement as follows: "The ratio of combined punitive damages ($57.5 million) to combined compensatory damages ($6,121,648) is 9.4 to 1." In Bocci III, we further stated that the ratio "exceeds by two and a half times the ratio of 4 to 1 that the Court suggested `might be close to the line of constitutional impropriety.'" Id. at 360 (quoting State Farm v. Campbell, 538 U.S. ___, 123 S.Ct. 1513, 1524, 155 L.Ed.2d 585 (2003)). We modify that sentence to read: "Indeed, it exceeds by more than two times the ratio of 4 to 1 that the Court suggested `might be close to the line of constitutional impropriety.'"

Edwards maintains that this alteration of the ratio of punitive to compensatory damage calculations should change our conclusion that the maximum permissible ratio under the circumstances of this case is 7 to 1. We disagree. While the Court in State Farm did note that "few awards exceeding a single-digit ratio between punitive and compensatory damages, to a significant degree, will satisfy due process," 538 U.S. at ___, 123 S.Ct. at 1524, that obviously does not mean that any award that has only a single-digit ratio will satisfy due process. We adhere to our conclusion in Bocci III that a 7-to-1 ratio is appropriate in this case.

We reject Edwards's remaining arguments on reconsideration without discussion.

Petition for reconsideration allowed; opinion modified and adhered to as modified.


Summaries of

Bocci v. Key Pharmaceuticals, Inc.

Oregon Court of Appeals
Nov 13, 2003
190 Or. App. 407 (Or. Ct. App. 2003)
Case details for

Bocci v. Key Pharmaceuticals, Inc.

Case Details

Full title:PAUL R. BOCCI, JR., guardian ad litem for Paul R. Bocci, III, an…

Court:Oregon Court of Appeals

Date published: Nov 13, 2003

Citations

190 Or. App. 407 (Or. Ct. App. 2003)
79 P.3d 908

Citing Cases

Simon v. San Paolo United States Holding Co., Inc.

Key Pharmaceuticals, Inc. (2003) 189 Ore.App. 349, 359 [ 76 P.3d 669, 675], mod. on other grounds and adhered…

Johnson v. Ford Motor Co.

dworks, Inc. v. Argonaut Ins.Company (2003) 109 Cal.App.4th 1020, 1054, footnote 34 [ 135 Cal.Rptr.2d 736]…